Skip to main content
Premium Trial:

Request an Annual Quote

Brits Back 500,000-Sample Biobank to Study Genes and Disease

NEW YORK, April 29 - British health agencies today announced plans to create a 500,000-person DNA sample bank for the study of the genetic and environmental causes of disease.

 

The Wellcome Trust, the British Medical Research Council and the Department of Health have initially committed 45 million pounds, or roughly $65.7 million, to establish and build the so-called biobank.

 

Under the plan, a handful of regional centers will recruit volunteers between the ages of 45 and 69 who are willing to provide medical history records and a DNA sample.

 

The bank will allow researchers to study the interactions between genes, environment and lifestyle in such diseases as cancer, heart disease, diabetes and Alzheimer's. The MRC will be accepting expressions of interest from potential hosts for the project during the next few months.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.